NCT06069336View on ClinicalTrials.gov

Nebulised 3% Hypertonic Saline Versus 0.9% Saline for Treating Patients Hospitalized With Acute Bronchiolitis

NACompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Bronchiolitis
Interventions
DRUG

Hypertonic saline

Nebulised 3% hypertonic saline (NEBU-dose hypertonic). Nebulisation will be performed by trained study nurses or by parents under the supervision of a nurse

DRUG

Normal saline

0,9% normal saline (NEBU-dose isotonic). Nebulisation will be performed by trained study nurses or by parents under the supervision of a nurse

Trial Locations (3)

55-100

Szpiatal im.Świętej Jadwigi Śląskiej, Trzebnica

02-091

Dziecięcy Szpital Kliniczny im. Polikarpa Brudzińskiego w Warszawie, Warsaw

58-309

Specjalistyczny Szpital im. Alfreda Sokołowskiego w Wałbrzychu, Wałbrzych

All Listed Sponsors
lead

Szpital im. Św. Jadwigi Śląskiej

OTHER